Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-008293
Filing Date
2023-05-18
Accepted
2023-05-18 17:20:05
Documents
1
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 form4-05182023_090554.html 4  
1 form4-05182023_090554.xml 4 5944
  Complete submission text file 0001415889-23-008293.txt   7236
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 138 THISTLE ROAD NORTH ANDOVER MA 08145
Business Address
Lucera Erick (Reporting) CIK: 0001697616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 23937182